Anti-mouse PD-L1 (B7-H1)-InVivo

製品コード：A2115         Batch: A211546

印刷

Anti-mouse PD-L1 (B7-H1)-InVivo (Clone:10F.9G2) monoclonal antibody reacts with mouse PD-L1 (also known as B7-H1, CD274). The 10F.9G2 antibody has been shown to block the interaction between PD-L1 and PD-1 and between PD-L1 and B7-1 (CD80).

製品説明

Formulation PBS Buffer, PH 7.4
Clone 10F.9G2
Immunogen Mouse CD274
Isotype Rat,IgG2b, κ
Application in vivo PD-L1 blockade,IHC (frozen),FCM
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Sterility 0.2 μM filtered
Purity 99%
Protein concentration 7.26 mg/ml
Endotoxin Level ＜1EU/mg

カスタマーフィードバック

A2115-Anti-mouse-PD-L1(B7-H1)-InVivo.gif

A2115-Anti-mouse-PD-L1-B7-H1-InVivo.gif

数据来源于[Data independently produced by , ]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma [ Cancer Commun (Lond), 2025, 10.1002/cac2.70036] PubMed: 40443016
Non-canonical PRC1.1 licenses transcriptional response to enable Treg plasticity in immune adaptation [ Mol Cell, 2025, 85(13):2517-2534.e6] PubMed: 40527320
PRMT3 Drives IDO1-Dependent Radioresistance and Immunosuppression by Promoting Kynurenine Metabolism in Non-Small Cell Lung Cancer [ Cancer Res, 2025, 10.1158/0008-5472.CAN-24-4162] PubMed: 41129671
LncRNA-CTD suppresses metastasis and immune evasion by modulating snail1 and MHC-I expression in colorectal cancer [ J Immunother Cancer, 2025, 13(9)e011766] PubMed: 40954077
NRIR promotes immune escape in hepatocellular cancer by regulating IFNγ-induced PD-L1 expression [ J Adv Res, 2025, S2090-1232(25)00133-X] PubMed: 40023249
Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity [ BMC Med, 2025, 23(1):387] PubMed: 40597177
Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response [ Cell Rep, 2025, 44(5):115679] PubMed: 40343797
Lipin1-dependent transcriptional inactivation of SREBPs contributes to selinexor sensitivity in multiple myeloma [ Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01553-3] PubMed: 40229499
ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition [ iScience, 2025, 28(2):111819] PubMed: 39995876
An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer [ Front Pharmacol, 2025, 16:1651165] PubMed: 40746718

人間や獣医の診断であるか治療的な使用のためにでない。